Home Sweden

Sweden

Stay informed about the latest biotech news happening in Sweden by subscribing to our newsletter.

Looking to expand your partner network? Build relationships with academic teams and biotechs.

How is the biotech industry in Sweden?

The biotech industry is thriving, driven by strong government support, a highly skilled workforce, and a culture of innovation. The country excels in areas such as biopharmaceuticals, medical technology, and life sciences research.

What are the main biotech hubs in Sweden?

The main biotech hubs include Stockholm, Uppsala, and Gothenburg. Stockholm houses major research institutions, biotech companies, and organizations like Karolinska Institute and Stockholm Science City. Uppsala is known for its strong biotech presence, driven by Uppsala University and the Biotech Uppsala initiative. Gothenburg is home to notable life science clusters, including AstraZeneca’s research facilities and the Sahlgrenska University Hospital.

Editor's Picks for Sweden

Best in Biotech

8 Swedish companies spearheading the country’s biotech scene

study biotechnology best universities Europe

Best in Biotech

The Best Universities to Study Biotechnology in Europe

water pollution solutions pharem biotech sweden uppsala

Startup Scout

This Biotech Cleans up Drugs from Sewage Using Enzymes

Latest Posts

Best in Biotech 28 May 2024

8 Swedish companies spearheading the country’s biotech scene

As Sweden’s life sciences sector continues to grow, we explore 8 biotech companies in Sweden that are leading the way in the industry.

May 28, 2024 - 9 minutesmins - By Willow Shah-Neville

biostatistics, clinical trials, LINK Medical Research

Early integration of biostatistics in clinical trials: a comprehensive guide

September 5, 2023 - 6 minutesmins - By Sudha Sundaram

News and Trends 14 Jul 2023

Calliditas reveals ‘encouraging results’ from head and neck cancer trial

Calliditas Therapeutics AB has announced interim data from its proof-of-concept phase 2 trial in patients with squamous cell carcinoma of the head and neck (SCCHN) with its lead NOX 1 and 4 inhibitor product candidate, setanaxib. The analysis reflects encouraging early clinical progression-free survival (PFS) results and is supportive of the presumed anti fibrotic mode […]

July 14, 2023 - 3 minutesmins - By Jim Cornall

In Depth 12 Jul 2023

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

With a combined market value of over $7 billion, the life science sectors in Sweden and Denmark are thriving, with over a thousand healthcare companies being set up over the past few years. Much of this is owing to the cross-border cluster that spans regions of eastern Denmark and southern Sweden, the Medicon Valley. Racking […]

July 12, 2023 - 10 minutesmins - By Roohi Mariam Peter

News and Trends 7 Jul 2023

Swedish researchers look to peptides to destroy viruses

A new study from Sweden shows how a type of peptide from a lactic acid bacterium destroys viruses, including coronavirus. The findings have resulted in a Swedish patent, with an international patent pending. “We’re hoping for a quick turnaround to allow this discovery to be utilised in antiviral treatments and as a complement to vaccine,” […]

July 7, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 3 Jul 2023

New osteoarthritis treatment for horses could work for humans

For the first time, an intervention that seems to slow down osteoarthritis (OA) progression has been presented. In a clinical study from the Swedish University of Agricultural Sciences and the University of Gothenburg, OA horses that received a novel drug treatment became completely free from lameness, with a simultaneous impediment of the joint tissue degradation. […]

July 3, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 30 Jun 2023

Scientists design new enzyme using Antarctic bacteria and computer calculations

For the first time, researchers have succeeded in predicting how to change the optimum temperature of an enzyme using large computer calculations. A cold-adapted enzyme from an Antarctic bacterium was used as the basis. The study is to be published in the journal Science Advances and is a collaboration between researchers at Uppsala University in […]

June 30, 2023 - 2 minutesmins - By Jim Cornall

News and Trends 15 Jun 2023

New way of identifying proteins supports drug development

All living cells contain proteins with different functions, depending on the type of cell. Researchers at the University of Gothenburg in Sweden have discovered a way to identify proteins even without looking at their structure. They say their method is faster, easier and more reliable than previous methods. Currently, the general view is that each […]

June 15, 2023 - 3 minutesmins - By Jim Cornall

News and Trends 5 Jun 2023

Bacterial resistance genes a ‘threat to human health’

Genes that make bacteria resistant to antibiotics are much more widespread in our environment than was previously realized. A new study, from Chalmers University of Technology and the University of Gothenburg in Sweden, shows that bacteria in almost all environments carry resistance genes, with a risk of them spreading and aggravating the problem of bacterial […]

June 5, 2023 - 5 minutesmins - By Jim Cornall

News and Trends 2 Jun 2023

Anocca raises $36.6M for large-scale development of cancer cell therapies

Anocca AB has raised SEK 400 million ($36.6 million) to further develop the discovery and manufacture of next generation cell therapies for cancer on an industrial scale. It will also allow Anocca to progress its first products into clinical trials. The financing brings together a group of existing and new investors, including Mellby Gård, AMF, […]

June 2, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 24 May 2023

Major progress as Swedish scientists get brain tumors to self destruct

Researchers at the University of Gothenburg in Sweden, working with French colleagues, have successfully developed a method able to kill the aggressive brain tumor glioblastoma. By blocking certain functions in the cell with a docked molecule, the researchers cause the cancer to die of stress.Cancer cells, especially those that form aggressive tumors, are in one […]

May 24, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 23 May 2023

Vicore reports new data from idiopathic pulmonary fibrosis study

Vicore Pharma Holding AB (publ), has announced an updated interim analysis of its AIR phase 2a trial with C21 in idiopathic pulmonary fibrosis (IPF). With 51 patients enrolled, the data demonstrates that C21 has the potential to transform the treatment of IPF and restore lung function. The disease is currently considered to be incurable and […]

May 23, 2023 - 4 minutesmins - By Jim Cornall

Swiss biotech going strong in 2024: 18 companies to put on your radar

The ABC of biotech startup funding

Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR

Special Olympics: How is biotechnology revolutionizing sports performance worldwide?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us